Steven A. Shallcross - Dec 15, 2022 Form 4 Insider Report for Theriva Biologics, Inc. (TOVX)

Role
CEO and CFO, Director
Signature
/s/ Steven A. Shallcross
Stock symbol
TOVX
Transactions as of
Dec 15, 2022
Transactions value $
$0
Form type
4
Date filed
12/16/2022, 05:16 PM
Previous filing
Dec 27, 2021
Next filing
Jan 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TOVX Stock Options (right to buy) Award $0 +475K $0.00 475K Dec 15, 2022 Common Stock 475K $0.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest pro rata on a monthly basis over 36 months.